Enliven Therapeutics, Inc.
ELVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001672619
In the last 90 days, Enliven Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 214 institutions reported holding it in 13F filings for Q2 2026, worth $4.06B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Enliven Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 61
- −2 vs. Q2 2023
- Shares held
- 39.1M
- −49.9K (−0.1%) vs. Q2 2023
- Total value
- $533.8M
- −$264.2M (−33.1%) vs. Q2 2023
- New holders
- 6
- 22 more added
- Sold out
- 8
- 22 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $4.06B |
| Q1 2026 | 171 | $2.43B |
| Q4 2025 | 126 | $960.9M |
| Q3 2025 | 134 | $1.22B |
| Q2 2025 | 125 | $1.19B |
| Q1 2025 | 122 | $983.9M |
| Q4 2024 | 114 | $1.12B |
| Q3 2024 | 102 | $1.22B |
| Q2 2024 | 93 | $1.13B |
| Q1 2024 | 74 | $780.8M |
| Q4 2023 | 62 | $539.8M |
| Q3 2023 | 61 | $533.8M |
| Q2 2023 | 63 | $797.9M |
| Q1 2023 | 45 | $735.0M |
| Q4 2022 | 36 | $74.7M |
| Q3 2022 | 31 | $18.8M |
| Q2 2022 | 26 | $13.1M |
| Q1 2022 | 31 | $26.2M |
| Q4 2021 | 35 | $33.6M |
| Q3 2021 | 38 | $62.5M |
| Q2 2021 | 31 | $86.3M |
| Q1 2021 | 40 | $92.9M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Enliven Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Covestor Ltd | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 9 | $123 | 0.00% | −7−43.8% | Reduced |
| Baystate Wealth Management LLC | 50 | $683 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 105 | $1.43K | 0.00% | +24+29.6% | Added |
| Allspring Global Investments Holdings, LLC | 566 | $7.73K | 0.00% | +566 | New |
| Metropolitan Life Insurance Co | 1,279 | $17.5K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 1,928 | $26.3K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,000 | $27.3K | 0.00% | +1,000+100.0% | Added |
| Amalgamated Bank | 2,270 | $31.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 3,347 | $45.7K | 0.00% | −7,476−69.1% | Reduced |
| Royal Bank of Canada | 4,707 | $65.0K | 0.00% | +1,632+53.1% | Added |
| Wells Fargo & Company | 5,740 | $78.4K | 0.00% | −3,130−35.3% | Reduced |
| Exchange Traded Concepts, LLC | 6,500 | $88.8K | 0.00% | −434−6.3% | Reduced |
| Tower Research Capital LLC (TRC) | 6,755 | $92.3K | 0.00% | +5,373+388.8% | Added |
| New York State Common Retirement Fund | 9,453 | $129.1K | 0.00% | +253+2.8% | Added |
| Deutsche Bank AG | 10,890 | $148.8K | 0.00% | +1,559+16.7% | Added |
| Mirae Asset Global Investments Co., Ltd. | 11,276 | $154.0K | 0.00% | 00.0% | Unchanged |
| SG Americas Securities, LLC | 11,460 | $157.0K | 0.00% | +11,460 | New |
| American International Group, Inc. | 11,649 | $159.1K | 0.00% | +414+3.7% | Added |
| MetLife Investment Management | 12,345 | $168.6K | 0.00% | 00.0% | Unchanged |
| AQR Capital Management LLC | 12,972 | $177.2K | 0.00% | +12,972 | New |
| Barclays PLC | 13,629 | $186.2K | 0.00% | −1,198−8.1% | Reduced |
| Alliancebernstein L.P. | 14,330 | $195.7K | 0.00% | +14,330 | New |
| Goldman Sachs Group Inc | 17,690 | $241.6K | 0.00% | −9,596−35.2% | Reduced |
| Bridgeway Capital Management, LLC | 17,950 | $245.2K | 0.01% | 00.0% | Unchanged |
| Invesco Ltd. | 18,766 | $256.3K | 0.00% | +18,766 | New |
| State of Wisconsin Investment Board | 18,948 | $258.8K | 0.00% | −3,234−14.6% | Reduced |
| Legal & General Group Plc | 19,665 | $268.6K | 0.00% | +1,610+8.9% | Added |
| California State Teachers Retirement System | 21,509 | $293.8K | 0.00% | −6,097−22.1% | Reduced |
| Credit Suisse AG | 22,850 | $312.1K | 0.00% | −1,205−5.0% | Reduced |
| Bank of America Corp | 23,106 | $315.6K | 0.00% | +6,063+35.6% | Added |
| JPMorgan Chase & Co | 26,495 | $361.9K | 0.00% | −4,160−13.6% | Reduced |
| JBF Capital, Inc. | 27,006 | $368.9K | 0.08% | −23,044−46.0% | Reduced |
| Morgan Stanley | 33,970 | $464.0K | 0.00% | +649+1.9% | Added |
| Rhumbline Advisers | 34,363 | $469.4K | 0.00% | −433−1.2% | Reduced |
| Swiss National Bank | 40,673 | $555.6K | 0.00% | −8,500−17.3% | Reduced |
| BML Capital Management, LLC | 50,000 | $683.0K | 0.63% | −24,232−32.6% | Reduced |
| Bank of New York Mellon Corp | 80,759 | $1.10M | 0.00% | −165−0.2% | Reduced |
| Nuveen Asset Management, LLC | 86,967 | $1.19M | 0.00% | +22,272+34.4% | Added |
| Acuta Capital Partners, LLC | 103,600 | $1.42M | 1.03% | −900−0.9% | Reduced |
| HighVista Strategies LLC | 124,587 | $1.70M | 0.79% | +3,514+2.9% | Added |
| Charles Schwab Investment Management Inc | 156,631 | $2.14M | 0.00% | +94,169+150.8% | Added |
| Northern Trust Corp | 194,534 | $2.66M | 0.00% | −1,406−0.7% | Reduced |
| Janus Henderson Group PLC | 276,416 | $3.77M | 0.00% | −94,578−25.5% | Reduced |
| Logos Global Management LP | 307,076 | $4.19M | 0.60% | 00.0% | Unchanged |
| Woodline Partners LP | 395,686 | $5.41M | 0.06% | +395,686 | New |
| Geode Capital Management, LLC | 432,972 | $5.92M | 0.00% | +18,528+4.5% | Added |
| State Street Corp | 470,852 | $6.43M | 0.00% | +4,601+1.0% | Added |
| Boxer Capital, LLC | 646,058 | $8.83M | 0.47% | −64,586−9.1% | Reduced |
| Frazier Life Sciences Management, L.P. | 1,050,483 | $14.3M | 0.95% | +219,500+26.4% | Added |
| Vanguard Group Inc | 1,151,817 | $15.7M | 0.00% | +9,313+0.8% | Added |
| Cormorant Asset Management, LP | 1,216,712 | $16.6M | 0.97% | −719,421−37.2% | Reduced |
| BlackRock Inc. | 1,567,532 | $21.4M | 0.00% | +21,057+1.4% | Added |
| Ra Capital Management, L.P. | 2,122,465 | $29.0M | 0.57% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 2,131,369 | $29.1M | 3.50% | +6,744+0.3% | Added |
| Citadel Advisors LLC | 2,351,491 | $32.1M | 0.03% | +55,281+2.4% | Added |
| Commodore Capital LP | 2,901,816 | $39.6M | 4.63% | +553,544+23.6% | Added |
| VR Adviser, LLC | 2,954,902 | $40.4M | 4.25% | +724,775+32.5% | Added |
| FMR LLC | 3,676,213 | $50.2M | 0.00% | −325,398−8.1% | Reduced |
| 5AM Venture Management, LLC | 5,160,975 | $70.5M | 20.29% | −637,500−11.0% | Reduced |
| OrbiMed Advisors LLC | 8,998,338 | $122.9M | 2.84% | 00.0% | Unchanged |
| Bank of Montreal | 0 | $0 | 0.00% | −191,893−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −36,150−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −23,762−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −11,685−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,531−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −9,900−100.0% | Sold out |
| Dorsey Wright & Associates | 0 | $0 | 0.00% | −1,375−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −33,550−100.0% | Sold out |